ESPERITE delays publication of 2016 Annual Report
April 26 2017 - 1:17AM
Zutphen, The Netherlands - 26 April
2017
Esperite N.V. (Euronext: ESP, the "Company" or
"Esperite") announces that additional time is
needed for the Company to publish its Annual Report for the fiscal
year ended 31 December 2016. Following the unanimous approval by
the Company's extraordinary general meeting of shareholders on 21
April 2017 for the subsequent tranches of convertible notes and
warrants under the recently announced external financing, the
Company's board of directors has decided to update certain
parameters related to the Company's budget for the fiscal years
2018 to 2021 that are relevant to the ongoing audit process in
connection with going concern and measurement of assets. As a
consequence, additional time is needed for the Company's auditor,
Ernst & Young Accountants LLP, to complete its audit procedures
and audit of the Company's Annual Report. Esperite expects to
publish its Annual Report and provide its Q1 2017 Trading Update on
or before 19 May 2017.
About ESPERITE N.V.
ESPERITE Group, listed at Euronext Amsterdam and Paris, is a
leading international company in regenerative and precision
medicine founded in 2000.
PR Update 2016 Annual
Report
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Esperite N.V. via Globenewswire